The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity
Abstract
Methylene blue has only recently been noted to cause severe central nervous system toxicity. Methylene blue is used for various conditions, including, intravenously, in methemoglobinemia, vasoplegia and as an aid to parathyroidectomy (at doses of 1–7.5 mg kg−1). This review of the current evidence concludes that 13 of 14 of the reported cases of CNS toxicity were serotonin toxicity that met the Hunter Serotonin Toxicity Criteria. That has important preventative and treatment implications. Serotonin toxicity is precipitated by the monoamine oxidase inhibitor (MAOI) property of methylene blue interacting with serotonin reuptake inhibitors. Serotonin toxicity is reviewed, using the lessons inherent in the methylene blue story and experience, to illustrate how the mechanisms and potency of serotonergic drugs interact to determine severity. Recent human data showed that an intravenous dose of only 0.75 mg kg−1 of methylene blue produced a peak plasma concentration of 500 ng ml−1(1.6 µM), indicating that the concentration in the central nervous system reaches a level that inhibits monoamine oxidase A. That is consonant with the actual occurrence of severe serotonin toxicity in humans at the dose of only 1 mg kg−1. It seems that all proposed uses of methylene blue entail levels that block monoamine oxidase, so cessation of serotonin reuptake inhibitors should be very carefully considered before using methylene blue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821 · cited 2×
“Good descriptions of the pathophysiology (Isbister and Buckley, 2005), clinical presentation (Boyer and Shannon, 2005), management and treatment (Gillman, 1999; Isbister et al.”
Background
Cited by
Intelligent Food Packaging: A Review of Smart Sensing Technologies for Monitoring Food Quality
Yousefi, H., Su, H.-M., Imani, S. M., Alkhaldi, K., M. Filipe, C. D., & Didar, T. F. (2019) · ACS Sensors · doi:10.1021/acssensors.9b00440 · Cited by 682
Recent advances in polymers and polymer composites for food packaging
Zhang, M., Biesold, G. M., Choi, W., Yu, J., Deng, Y., Silvestre, C., & Lin, Z. (2022) · Materials Today · doi:10.1016/j.mattod.2022.01.022 · Cited by 335
Luo, X., Zaitoon, A., & Lim, L. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12942 · Cited by 294
Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions
Scotton, W. J., Hill, L. J., Williams, A. C., & Barnes, N. M. (2019) · International Journal of Tryptophan Research · doi:10.1177/1178646919873925 · Cited by 267
Gillman, P. K. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1932-y · Cited by 255
Self-citation
Metadata
- Authors
- Gillman, P. K.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2010-02-08
- Volume
- 25
- Issue
- 3
- Pages
- 429-436
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2170622299
- Cited by
- 182
- References
- 1
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. https://app.cochat.ai/papers/10.1177/0269881109359098
- The paper
- Gillman, P. K. (2011). CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. Journal of Psychopharmacology. https://doi.org/10.1177/0269881109359098
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.